Financial implications of surgical complications in pediatric liver transplantation

Area of Science:

• Pediatric Surgery
• Transplantation Medicine
• Health Economics

Background:

• Surgical complications are frequent and costly after pediatric liver transplantation.
• Understanding the financial impact on different stakeholders is crucial.

Purpose of the Study:

• To determine the incremental costs of surgical complications in pediatric liver transplantation.
• To identify which parties (medical center or payer) bear these costs.

Main Methods:

• Retrospective review of 36 pediatric liver transplant patients (age <=12 years) transplanted between July 2002 and December 2005.
• Analysis of recipient data and financial information to assess the association between complications and costs/reimbursements.
• Multivariate regression models to identify independent predictors of increased costs and reimbursements.

Main Results:

• Acute renal failure (ARF) and hepatic artery thrombosis (HAT) were independently associated with significant increases in hospital costs (median incremental costs of $238,990 and $125,650, respectively).
• ARF and HAT also independently increased median payer reimbursements (median incremental costs of $231,611 and $125,287, respectively).
• No complications were independently associated with decreased hospital profit margins.

Conclusions:

• Surgical complications in pediatric liver transplantation impose substantial financial burdens on both hospitals and payers.
• Quality improvement initiatives targeting complications like ARF and HAT could yield significant financial benefits for all stakeholders.
• Payers have the largest financial interest in reducing these complication-related costs.